Filip Bergquist

16PUBLICATIONS
38CO-AUTHORS
PhysiotherapyNeurology and neuromuscular diseasesLiquid biopsiesSystems physiologyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 04, 2026
Outcomes of rehabilitation following device-aided therapy start in parkinson's disease: a randomized controlled trial.

|May 13, 2026
Weekly Variability of an Objective Bradykinesia Score in Parkinson's Disease-An Observational Longitudinal Study.

|May 07, 2026
Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results.

|Mar 12, 2026
Wearable sensor measurements in relation to clinical characteristics and mortality in patients with Parkinson's disease.

Daniel von Below, Susanna M Wallerstedt, Filip Bergquist

|Mar 17, 2025
NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy.

Per Svenningsson, Per Odin, Filip Bergquist

|Dec 03, 2024
Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease.

Mezin Öthman, Filip Bergquist, Per Odin

Pageof 3

Frequent Collaborators

5 joint publications

Dag Nyholm

4 joint publications

Per Svenningsson

3 joint publications

Bruno Bergmans

3 joint publications

Nil Dizdar